Ratings Kirin Holdings Company, Limited

Equities

2503

JP3258000003

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,273 ^JPY	+0.04%		+2.60%	+10.02%

Mar. 29	Nightingale Health Closes Purchase of Japan's Welltus	MT
Mar. 29	Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	CI

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Brewers

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
KIRIN HOLDINGS COMPANY, LIMITED	+10.02%	11.69B		B+
ANHEUSER-BUSCH INBEV SA/NV	-3.94%	119B		A-
DELTA CORPORATION LIMITED	+384.45%	67.41B	-	C-
CONSTELLATION BRANDS, INC.	+7.57%	47.58B		C+
AMBEV S.A.	-12.53%	36.89B		B-
HEINEKEN HOLDING N.V.	0.00%	23.13B	-	B+
CARLSBERG A/S	+12.68%	19.06B		B
BUDWEISER BREWING COMPANY APAC LIMITED	-25.17%	18.42B		B
ASAHI GROUP HOLDINGS, LTD.	+3.94%	17.59B		A-
CHINA RESOURCES BEER (HOLDINGS) COMPANY LIMITED	+6.29%	15.06B		B-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes